Madrigal Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
MDGL
CUSIP
558868105
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 335 23.7 M $7.17 B
2025 Q1 350 23.6 M $7.82 B
2024 Q4 322 23.0 M $7.08 B
2024 Q3 289 22.7 M $4.77 B
2024 Q2 296 23.1 M $6.48 B
2024 Q1 316 21.8 M $5.83 B
2023 Q4 262 20.1 M $4.65 B
2023 Q3 235 17.4 M $2.54 B
2023 Q2 241 14.9 M $3.45 B
2023 Q1 255 14.0 M $3.38 B
2022 Q4 225 14.8 M $4.28 B
2022 Q3 157 11.8 M $770 M
2022 Q2 154 12.0 M $858 M
2022 Q1 154 12.3 M $1.20 B
2021 Q4 163 12.1 M $1.03 B
2021 Q3 146 11.0 M $876 M
2021 Q2 162 11.2 M $1.09 B
2021 Q1 149 12.2 M $1.43 B
2020 Q4 149 12.5 M $1.39 B
2020 Q3 143 11.6 M $1.38 B
2020 Q2 140 11.3 M $1.28 B
2020 Q1 118 11.1 M $741 M
2019 Q4 134 10.6 M $966 M
2019 Q3 123 9.64 M $831 M
2019 Q2 145 9.79 M $1.03 B
2019 Q1 159 9.63 M $1.21 B
2018 Q4 156 9.07 M $1.02 B
2018 Q3 178 8.78 M $1.88 B
2018 Q2 158 8.16 M $2.28 B
2018 Q1 101 6.38 M $745 M
2017 Q4 92 5.13 M $471 M
2017 Q3 53 2.67 M $120 M
2017 Q2 42 2.05 M $33.3 M
2017 Q1 33 1.53 M $23.6 M
2016 Q4 32 1.35 M $20.1 M
2016 Q3 32 1.01 M $12.8 M
2016 Q2 1 79.6 k $21.0 k